Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. NVDA
2. CRWV
3. SPY
4. BAC
5. VRNS
6. FMC
7. RKLB
8. BLK
9. CAT
10. AA

Go back to Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock

Proteostasis Therapeutics (PTI) Announces Withdrawal of Equity Offering Due to Market Conditions

March 21, 2018 6:28 AM EDT

Proteostasis Therapeutics, Inc. (Nasdaq: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, announced today that it is not proceeding with its proposed public offering... More

Proteostasis Therapeutics (PTI) Mentioned Cautiously by Short Seller Kerrisdale

March 20, 2018 9:32 AM EDT

Proteostasis Therapeutics (NASDAQ: PTI) Mentioned Cautiously by Short Seller Kerrisdale

We're short... More